CHMP Recommends Approval of Galderma’s Nemolizumab for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis in the European Union December 13, 2024
ExpreS2ion announces approval to initiate a Phase I clinical trial of ES2B-C001, its novel therapeutic vaccine, being developed for HER2-expressing breast cancer December 2, 2024
Roc Oil Company Pty Limited extends the acceptance period for the recommended cash offer to the shareholders of Tethys Oil AB due to pending regulatory approval in Lithuania November 29, 2024
The board of Peptonic resolves, subject to the approval a subsequent general meeting, on a rights issue of units of approximately SEK 26.5 million November 29, 2024
Noble Corporation plc announces approval of request for removal from trading and official listing on Nasdaq Copenhagen November 18, 2024
Uptime Launches Enhanced M&O Stamp of Approval to Accelerate Improvements in Data Center Operational Resiliency November 7, 2024
PM-Vidyalaxmi scheme gets cabinet approval, to provide collateral, guarantor free education loans up to ₹7.5 lakh November 6, 2024
